| Co-Authors | |
|---|---|
| Authors | No. of Publications |
| lai, cl | 16 |
| wong, dkh | 13 |
| leung, wk | 12 |
| liu, ksh | 11 |
| seto, wk | 11 |
| seto, wkw | 11 |
| yuen, mf | 11 |
| hung, ifn | 9 |
| cheung, ksm | 8 |
| fung, j | 8 |
| yuen, rmf | 7 |
| liu, shk | 6 |
| kwong, yl | 5 |
| lie, akw | 5 |
| mak, ly | 5 |
| but, dyk | 4 |
| chan, tsy | 4 |
| fung, jyy | 4 |
| singh, ghh | 4 |
| tong, tsm | 4 |
| yuen, jch | 4 |
| hsu, asj | 3 |
| hung, fni | 3 |
| ko, klm | 3 |
| law, wl | 3 |
| lo, osh | 3 |
| mak, lyl | 3 |
| to, wpe | 3 |
| wong, sy | 3 |
| chan, syt | 2 |
| cheung, ks | 2 |
| hwang, yy | 2 |
| hwang, yyg | 2 |
| ko, kl | 2 |
| ko, mkl | 2 |
| lau, ehy | 2 |
| lo, sh | 2 |
| tan, vpy | 2 |
| to, wp | 2 |
| tong, t | 2 |
| au, wy | 1 |
| chan, a | 1 |
| chan, jfw | 1 |
| chan, sc | 1 |
| chen, l | 1 |
| chok, ksh | 1 |
| chong, ck | 1 |
| chow, n | 1 |
| cloherty, g | 1 |
| gersch, j | 1 |
| guo, c | 1 |
| huang, fy | 1 |
| lam, k | 1 |
| lau, skp | 1 |
| law, mwk | 1 |
| leung, ayh | 1 |
| leung, sy | 1 |
| lo, cm | 1 |
| lui, tkl | 1 |
| seto, wk | 1 |
| sing, k | 1 |
| singh, g | 1 |
| so, cc | 1 |
| sridhar, s | 1 |
| tang, m | 1 |
| to, ewp | 1 |
| to, kkw | 1 |
| tong, sm | 1 |
| trendell-smith, nj | 1 |
| tse, e | 1 |
| tse, h | 1 |
| tsui, v | 1 |
| wong, t | 1 |
| woo, pcy | 1 |
| wu, jt | 1 |
| yuen, ky | 1 |
| Keywords in Publications | |
|---|---|
| keywords | No. of Authors |
| gastroenterology | 20 |
| medical sciences | 20 |
| hav | 9 |
| hbv | 9 |
| hcv | 9 |
| hev | 9 |
| immigration | 9 |
| vaccination | 9 |
| chronic hepatitis b | 8 |
| hla‐dp | 8 |
| ifn‐γ pathway | 8 |
| entecavir | 7 |
| etv | 7 |
| hbsag | 7 |
| nucleoside analogue | 7 |
| surface antigen | 7 |
| colon neoplasms | 6 |
| colonoscopy | 6 |
| curative colectomy | 6 |
| follow up | 6 |
| recurrence | 6 |
| endocrinology | 5 |
| 13c-urea breath test | 4 |
| antibiotics | 4 |
| hbv dna | 4 |
| helicobacter pylori - treatment | 4 |
| hematopoietic stem cell transplantation | 4 |
| hepatitis b | 4 |
| immunosuppressive agents - administration and dosage | 4 |
| living donors | 4 |
| multiple myeloma - therapy | 4 |
| nucleos(t)ide analogs | 4 |
| precursor cell lymphoblastic leukemia-lymphoma - drug therapy - etiology | 4 |
| resistance | 4 |
| colorectal cancer | 2 |
| serrated lesion | 2 |
| sessile serrated adenoma/polyp | 2 |